Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | THY1 |
| Upstream (Parents) |
|---|
| (<<) COL1A1 → THY1 |
| (<<) COL5A1 → THY1 |
| Downstream (Children) |
|---|
| THY1 → RGS16 (>>) |
| THY1 → PLXDC1 (>>) |
| THY1 → VIM (>>) |
| THY1 → SERPINH1 (>>) |
| THY1 → SSPN (>>) |
| THY1 → TYR (>>) |
| THY1 → ACTA2 (>>) |
| THY1 → SFRP4 (>>) |
| THY1 → C20orf103 (>>) |
| THY1 → ELN (>>) |
| THY1 → KIRREL (>>) |
| THY1 → EDNRA (>>) |
| THY1 → PRR16 (>>) |
| THY1 → MGP (>>) |
| THY1 → VCAN (>>) |
| THY1 → PRKG1 (>>) |
| THY1 → NTM (>>) |
| THY1 → MN1 (>>) |
| THY1 → TUBA1A (>>) |
| THY1 → CTGF (>>) |
| THY1 → EDIL3 (>>) |
| THY1 → PDZRN3 (>>) |
| THY1 → FILIP1L (>>) |
| THY1 → RCN3 (>>) |
| THY1 → L2HGDH (>>) |
| THY1 → ID4 (>>) |
| THY1 → PLVAP (>>) |
